Clinical Trial Update: Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial report evaluating the safety and immune response of a prime-boost vaccination schedule in HIV-infected participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: COMPLETED